title: An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling.
authors.forename: J
authors.initials: J
authors.lastname: Flach
authors.forename: F
authors.initials: F
authors.lastname: Dicker
authors.forename: S
authors.initials: S
authors.lastname: Schnittger
authors.forename: S
authors.initials: S
authors.lastname: Schindela
authors.forename: A
authors.initials: A
authors.lastname: Kohlmann
authors.forename: T
authors.initials: T
authors.lastname: Haferlach
authors.forename: W
authors.initials: W
authors.lastname: Kern
authors.forename: C
authors.initials: C
authors.lastname: Haferlach
mesh_terms: D002471:Cell Transformation, Neoplastic; D002869:Chromosome Aberrations; D004273:DNA, Neoplasm / Q000235:genetics; D018450:Disease Progression; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D019656:Loss of Heterozygosity; D009154:Mutation / Q000235:genetics*; D009190:Myelodysplastic Syndromes / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics*; D016609:Neoplasms, Second Primary / Q000235:genetics*; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011379:Prognosis
chemical_list: D004273:DNA, Neoplasm; D009363:Neoplasm Proteins